Author Archives: admin


Stem Cell Clinic > Articles by: admin

Scientists to speed creation of pig vaccines – FarmingUK

By Stell Cell Research

Scientists want to combat African swine fever, a highly contagious, potentially fatal disease, and Porcine Reproductive and Respiratory Syndrome, found in commercial herds

Scientists are developing a method to speed the creation of vaccines for devastating pig diseases, such as African swine fever.

British researchers are aiming to establish a reliable, large-scale system to develop and test vaccines for viral infections.

Stem cell technology will be used to develop a source of white blood cells, identical to those affected by disease in pigs, which can be used to develop vaccines containing live virus.

The team, involving scientists from the Roslin Institute and the Animal and Plant Health Agency (APHA), are particularly investigating control strategies against African swine fever virus.

Results from the study are expected to shed light on how diseases such as ASF target white blood cells, and how the cells respond to infection.

The approach seeks to improve on current vaccine testing methods, which include using blood cells derived from other animal species, or from other types of cells that resemble blood cells.

Stem cells those in early stage of development, which can differentiate into blood cells hold promise as a source of blood cells as they are likely to be free of contamination with disease, leading to accurate, reliable results.

Genetic modification techniques may also enable researchers to develop more efficient production of blood cells.

This approach may also enable scientists to explore whether lab-produced blood cells are able to contain high levels of virus, making them effective for vaccine development.

In addition, the application of genome editing technology to blood and virus cells could aid understanding of the role of genes in infectivity, immune response, and resistance to disease.

Dr Tom Burdon, research group leader at Roslin Institute said: "Stem cell technology applied to vaccine development can not only speed the delivery of results but limit the need for research involving animals.

"We hope that our efforts will aid the search for effective vaccines against serious diseases, which affect millions of animals and incur great cost to farmers."

See the original post:
Scientists to speed creation of pig vaccines - FarmingUK

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color – KPFA – 94.1FM

By Stem Cell Treatment

Davey D brings us audio from todays press conference held at The Way Christian Center in Berkeley Ca. Less than 12 hours after The Way Christian Center placed a Black Lives Matter banner, someone set fire to several trash cans positioned at the back of the church. The act of arson, damaged a portion of the building (see photos below) and has created fear and anger in the community.

Later we speak with Jess Tom and Carol Gillespie about treatment for blood-related cancers, the shortage of stem cell donors of color and the need to improve the registries. Seventy percent of patients wont have a match in their families and must find an unrelated donor. Patients are more likely to match donors who share the same ethnic background, but the lack of diversity on the Be The Match national registry makes it difficult for patients to find one. The Asian American Donor Program (AADP,

Guests:

Pastor Michael McBride (known as Pastor Mike) The fire was an act of terror, said Pastor Michael McBride, who leads the 48-year-old Way Christian Church.

Pastor Michael McBride is a native of San Francisco, CA. and has been active in ministry for almost 20 years. In June 2005, Pastor McBridelaunched a new ministry, The Way Christian Center in West Berkeley, where he presently serves as thePastor.

Carol Gillespie, Executive Director, Asian American Donor Program

Carol Gillespie is one of the original members of the Board of Directors for the Asian American Donor Program (AADP) when it was founded in 1989. She volunteered for AADP for3 years before accepting the position as Project Administrator in 1992. In 2002, Gillespie was selected as AADPs Executive Director and is currently serving in that position.

Jess Tom, Chef, Author, and TV Guest

Jess Tom is the sister of Andrew, who at 29 years old was living his dream and engaged to the love of his life. In May 2020 Andrew went to the doctor for swollen lymph nodes. A couple of days later, he was diagnosed withmixed phenotype acute leukemia (MPAL), a rare and aggressive form of leukemia. MPAL accounts for only 2-5% of all leukemias. The only way he can beat the illness is with a stem cell transplant.

In order to have a stem cell transplant, first a stem cell match for Andrew must be found. No one in Andrews family is a match. As being a match is genetically based, Andrews stem cell match will most likely be someone who is Chinese.Chinese donors only make up 0.7% of the national donor registry, leaving him with only a 43% chance of finding a perfect match.

Jess Tom has been working with the Asian American Donor Program, a nonprofit organization, to encourage Chinese Americans to register as potential stem cell donors. Sheis a chef and winner of season 14 ofFood Network Star. Jess Tom is a writer and food blogger living in Brooklyn.

She is the author ofFOOD WHORE: A Novel of Dining & Deceitpublished by William Morrow/HarperCollins. The paperback edition was released in 2015.FOOD WHORE, Jess first novel, merges her love of food and fiction.

You can find Jess on stage, online and on television, appearing on the Food Network, Good Morning America, the Today Show, and more.She has worked on initiatives with food trucks, restaurants, hospitality startups, and citywide culinary programs.

Read more:
Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color - KPFA - 94.1FM

What Is the Impact of COVID-19 on Cancer Stem Cells Market During Projected Period of 2020-2026? – Owned

By Stem Cell Treatment

According to a study, Cancer Stem Cells Market by Research Dive, the global market will surpass $1,722.7 million by 2026. Rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the year 2026.

Rising tension of cancer all over the world is one of the significant factor which drives the growth of cancer stem cells market. According to the World Health Organization (WHO), one out of six deaths are occurs due to cancers such as breast cancer, lungs cancer and others. The causes for the growing cases of cancer patients include urban air pollution, sexually transmitted HPV infection, alcohol consumption, poor intake of fruit and vegetables. Moreover, late-stage presentation and inaccessible diagnosis are the common factor which increases risk of cancer. On the other hand, stem cell research has capability to manufacture different types of medicines for diseases along with finding drugs that can be used for treatment of cancer.

Connect with Analyst to Reveal How COVID-19 Impacting On Cancer Stem Cells Market:https://www.researchdive.com/connect-to-analyst/32

However, issues such as expensive stem cell therapy treatments & strict international rules and are hampering the global cancer stem cells market growth. Such therapy utilizes living cells to treat disease coupled with processes like collecting, altering, storing and applying to technology. Thus, the cost of stem cell therapy ranges between $5,000 to $8,000 per stem cell treatment also it can be around $25,000 or more than that. Researchers of Tel Aviv University introduced newly advanced biosensor which can target leukemic stem cells. They are more focusing on decreasing the rate of relapse in blood cancer by targeting most malignant leukemic stem cells. Such latest technological advancements anticipated to drive the growth of market. Stem cell research is the rapidly growing medical practice in Turkey. Therefore, this country is now recognized as rising star of Europe in stem cell. Turkish hospitality and friendliness is well deserved along with high quality, low cost stem cell treatment, modern laboratory equipment creating enormous opportunities for the investors of stem cells.

Breast cancer market will surpass $295.0 million in the year 2026, and is anticipated to rise at 10.4% CAGR during the estimate period. The cancer stem cells market for bladder is anticipated to increase at 11.2% CAGR, and will surpass $275.8 million by 2026, rising from $117.9 million in 2018.

Global market for stem cell based cancer therapy was $440.3 million by end of 2018 and is anticipated to grow at 9.3% CAGR. This is majorly due to the rising advancements in stem cell therapy of Asia-Pacific and Europe region.

Click Here to Download Sample Copy of the Report at:https://www.researchdive.com/download-sample/32

North America cancer stem cell market is generated revenue of $365.64 million by end of 2018 and is anticipated to rise at 10% CAGR during the analyzed period. Asia-Pacific market registered a growth rate of 11.2% during the forecast period. This market will surpass $367.68 million by 2026, growing from $157.26 million in 2018. China, India, and Japan are the key contributors to the growth of regional market.

Some of the major players in the global cancer stem cells market are AdnaGen GmbH, Advanced Cell Diagnostics, Inc., AVIVA Biosciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc. and Silicon Biosystems, S.p.A. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development etc. For instance, in January 2019, Fluxion Biosciences launched custom liquid biopsy NGS (Next Generation Sequencing) panel development. In liquid biopsy, NGS has been applied to sequencing of circulating tumor DNA. This technology has led to noteworthy reduction in the cost of sequencing coupled with improved accuracy.

Contact Us:

Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) + 91 (788) 802-9103 (India) +1 (917) 444-1262 (US) Toll Free : +1 -888-961-4454 Email:[emailprotected] LinkedIn:https://www.linkedin.com/company/research-dive Twitter:https://twitter.com/ResearchDive Facebook:https://www.facebook.com/Research-Dive Blog:https://www.researchdive.com/blog Follow us on:https://covid-19-market-insights.blogspot.com

See the article here:
What Is the Impact of COVID-19 on Cancer Stem Cells Market During Projected Period of 2020-2026? - Owned

Cell Culture Market Research Report by Product, by End User, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – GlobeNewswire

By Stell Cell Research

July 30, 2020 19:07 ET | Source: ReportLinker

New York, July 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Culture Market Research Report by Product, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05940079/?utm_source=GNW

The Global Cell Culture Market is expected to grow from USD 16,371.34 Million in 2019 to USD 33,826.78 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.85%.

Market Segmentation & Coverage: This research report categorizes the Cell Culture to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Cell Culture Market studied across Consumables and Equipment. The Consumables further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Equipment further studied across Bioreactors, Storage Equipment, and Supporting Equipment.

Based on End User , the Cell Culture Market studied across Cell Banks, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.

Based on Application , the Cell Culture Market studied across Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine.

Based on Geography, the Cell Culture Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Culture Market including CellGenix GmbH, Corning Incorporated, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, GE Healthcare, Hi-Media Laboratories, Invivogen, Lonza Group AG, Merck KGaA, Miltenyi Biotec, Promocell, Sartorius AG, and Thermo Fisher Scientific Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Culture Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Culture Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Culture Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Culture Market? 4. What is the competitive strategic window for opportunities in the Global Cell Culture Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Culture Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Culture Market? Read the full report: https://www.reportlinker.com/p05940079/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

More:
Cell Culture Market Research Report by Product, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire

Research report covers the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecasts and Growth, 2019-2025 – Market Research…

By Stell Cell Research

This report presents the worldwide Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size (value, production and consumption), splits the breakdown (data status 2018 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2601860&source=atm

The report provides a valuable source of insightful data for business strategists and competitive analysis of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market. It provides the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies study provides comprehensive data which enhances the understanding, scope and application of this report.

The key players covered in this study Orange County Hair Restoration Center Hair Sciences Center of Colorado Anderson Center for Hair Evolution Hair Loss Institute Savola Aesthetic Dermatology Center Virginia Surgical Center Hair Transplant Institute of Miami Colorado Surgical Center & Hair Institute

Market segment by Type, the product can be split into Platelet Rich Plasma Injections Stem Cell Therapy Market segment by Application, split into Dermatology Clinics Hospitals

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players. To present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2601860&source=atm

Regional Analysis For Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market:

For comprehensive understanding of market dynamics, the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Influence of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market report:

-Comprehensive assessment of all opportunities and risk in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market recent innovations and major events.

-Detailed study of business strategies for growth of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market-leading players.

-Conclusive study about the growth plot of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market for forthcoming years.

-In-depth understanding of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market-particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report has 150 tables and figures browse the report description and TOC:

Table of Contents of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

1 Study Coverage

1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Type

1.4.2 Hydraulic Dredges

1.4.3 Hopper Dredges

1.4.4 Mechanical Dredges

1.5 Market by Application

1.5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Application

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2601860&licType=S&source=atm

2 Executive Summary

2.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size

2.1.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue 2014-2025

2.1.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production 2014-2025

2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Manufacturers

2.3.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Manufacturing Base Distribution, Headquarters

2.3.2.2 Manufacturers Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product Offered

2.3.2.3 Date of Manufacturers Enter into Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

2.4 Key Trends for Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Markets & Products

3 Market Size by Manufacturers

3.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production by Manufacturers

3.1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production by Manufacturers

3.1.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production Market Share by Manufacturers

3.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue by Manufacturers

3.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue by Manufacturers (2019-2025)

3.2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue Share by Manufacturers (2019-2025)

3.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information.

Read the original here:
Research report covers the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecasts and Growth, 2019-2025 - Market Research...

Identification and Treatment of Tuberculosis in Pediatric Recipients o | IDR – Dove Medical Press

By Stem Cell Treatment

Xiaodong Wang1,2 ,* Uet Yu2 ,* Xiaonan Li,3 Chunjing Wang,2 Qian Zhang,2 Chunlan Yang,2 Xiaoling Zhang,2 Yu Zhang,2 Ying Wang,2 Yuejie Zheng,3 Jikui Deng,4 Weiguo Yang,5 Guosheng Liu,1 Guofang Deng,6 Sixi Liu,2 Feiqiu Wen1,2

1Department of Pediatrics, First Affiliated Hospital of Jinan University, Guangzhou, Peoples Republic of China; 2Department of Hematology and Oncology, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 3Department of Respiratory Diseases, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 4Department of Infectious Diseases, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 5Pediatric Intensive Care Unit, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 6Guangdong Key Laboratory for Emerging Infectious Diseases & Shenzhen Key Laboratory of Infection and Immunity, Shenzhen Third Peoples Hospital, Shenzhen, Guangdong, Peoples Republic of China

*These authors contributed equally to this work

Correspondence: Sixi Liu; Feiqiu Wen Email tiger647@126.com; fwen62@163.com

Background: Tuberculosis is a rare but life-threatening complication in patients who received hematopoietic stem cell transplantation. Early identification and intervention are essential to prevent severe complications. Case Presentation: We report two pediatric patients who developed tuberculosis after receiving hematopoietic stem cell transplantation for thalassemia major among 330 recipients between January 2012 and August 2019. Patient A presented with pulmonary tuberculosis and patient B presented with lymph node tuberculosis mimicking post-transplantation lymphoproliferative disorder associated with EpsteinBarr virus reactivation. Patient Bs condition was deteriorated, and shortly after the initiation of anti-tuberculosis therapy, the patient was found to have disseminated pulmonary tuberculosis. Patient B was also found to have tuberculous granulomas, an uncommon manifestation of tuberculosis causing severe airway obstruction. Both patients developed critical respiratory failure and required mechanical ventilation; however, they recovered with almost full resolution of pulmonary lesions after multiple treatment adjustments. Conclusion: Tuberculosis must be carefully evaluated in all pediatric patients that receive hematopoietic stem cell transplantation, regardless of the identification of other pathogens. Prophylactic tuberculosis therapy should be considered for high-risk pediatric hematopoietic stem cell transplantation recipients from tuberculosis-endemic regions.

Keywords: tuberculosis, hematopoietic stem cell transplantation, thalassemia, pediatric

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more here:
Identification and Treatment of Tuberculosis in Pediatric Recipients o | IDR - Dove Medical Press

Precision Medicine Achieves Our Goals and Makes Money in Stocks – Banyan Hill Publishing

By Stem Cell Doctors

A year ago, measles was in the news. We saw more cases in 2019 than we had in more than a decade.

Today, its a virus that has become a global pandemic.

We have a vaccine for measles and were working toward one for the coronavirus.

Having a vaccine will go a long way toward relieving the angst of society. You see, vaccines are one way to achieve herd immunity. (Natural infection is the other.) This is when a large portion of a community becomes immune to a disease. When that happens, the spread of the disease becomes less likely.

This vaccine will happen. In part, because we want it to and because of the amazing advances weve made in the world of medicine.

Were seeing amazing changes in precision medicine today. As the name implies, it has made the practice of medicine more precise. We are sequencing genes to better understand disease at the cells. This has allowed us to personalize medicine.

Per the U.S. Centers for Disease Control and Prevention, sickle cell disease (SCD) affects 100,000 people in the U.S. alone. A disproportionate percentage of them are African American.

Normally healthy round red blood cells become hard and sticky. They look like a C-shaped tool called a sickle.

The cells die early, causing a constant shortage of red blood cells. The shape of these cells also causes them to get stuck and clog blood flow. This results in pain, infection and even stroke.

Gene therapy modifies someones DNA to treat disease.

In 2017, doctors announced they had used the therapy to cure a teens SCD and the painful symptoms that went with it.

They took some of his bone marrow stem cells, gave the cells extra versions of a needed gene and put them back in his body.

The blood tests show hes cured.

Medical professionals are excited about the prospects of gene therapy for other ailments like hemophilia and cystic fibrosis as well.

Immunotherapy is a treatment that helps your immune system fight cancer. Its a biological therapy. This means it uses substances made from living organisms.

One reason cancer cells thrive is they know how to hide from your immune system. Some of the immunotherapies were working on can mark cancer cells so its easier for your system to find them. Others boost your immune system, so it just works better against the diseased cells.

One version of this is T-cell therapy.

Kids who get leukemia most often suffer from ALL, or acute lymphoblastic leukemia.

In 2017, scientists conducted a trial on patients who had a less than 20% chance of survival using current treatments. Of those patients, 93% using the therapy achieved complete initial remission. Half remained in complete remission a year later.

Testing continues, but this is a huge leap forward.

Human ingenuity will help us beat the coronavirus, too.

Weve been fighting viruses for a long time. We have hundreds of years of insight. And weve never wanted a vaccine more than we do today.

Remdesivir is one of our most promising drugs to fight the coronavirus. Gilead Sciences first created it to treat Ebola, another virus.

Precision medicine will help, too.

More than 1,800 COVID-19 trials are taking place around the world right now. The U.S. is doing the most, but this is truly a global effort.

We will achieve our goal.

Never bet against us.

Further, if there ever was one, now is the time to come together. To use more compassion than (hate-filled) passion. The results will surprise us if we embrace kindness today.

Good investing,

Brian Christopher Editor, Profit Line

P.S. In his Automatic Fortunes investing service, Ian King follows the latest advancements in precision medicine. He has already invested in names that benefit from it. Precision medicine will be a key player in the rise of the Great American Reset. Click here to learn more. Youll be happy that you did.

Read this article:
Precision Medicine Achieves Our Goals and Makes Money in Stocks - Banyan Hill Publishing

Trending Now: COVID-19 impact on 3D Cell Cultures Market Variables, Information, Emerging Trends, Analysis and Forecast 2020-2026 | Sigma, Lonza, 3D…

By Stell Cell Research

3D Cell Cultures Market 2020: Latest Analysis

Chicago, United States:- The report titled Global 3D Cell Cultures Market is one of the most comprehensive and important additions to Report Hive Research archive of market research studies. It offers detailed research and analysis of key aspects of the global 3D Cell Cultures market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global 3D Cell Cultures market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global 3D Cell Cultures market is carefully analyzed and researched about by the market analysts.

Top Players of 3D Cell Cultures Market are Studied: Sigma, Lonza, 3D Biomatrix, Ams Bio, Life Technologise, Microtissues, Labome, Tecan, Lena Bio, 3D Biotek, Scivax Life Sciences, Corning Incorporated

Download Free Sample PDF (including full TOC, Tables, and Figures) of 3D Cell Cultures Market Research 2020-2026:- @

According to Our Research study, over the next five years the 3D Cell Culturesmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in 3D Cell Culturesbusiness. 3D Cell Cultures market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia. Sales forecast by type/application from 2021-2026 Industry chain, downstream and upstream information is also included. World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders. Our Researchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

NOTE:Due to the pandemic, we have included a special section on the Impact of COVID 19 on the 3D Cell Cultures Market which would mention How the Covid-19 is Affecting the 3D Cell Cultures Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for 3D Cell Cultures Players to Combat Covid-19 Impact.

Global 3D Cell Cultures Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of Report Hive Research the 3D Cell Cultures market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2026.

Our exploration specialists acutely ascertain the significant aspects of the global 3D Cell Cultures market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of 3D Cell Cultures market situation. In this 3D Cell Cultures report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global 3D Cell Cultures report comprises of primary and secondary data which is exemplified in the form of pie outlines, 3D Cell Cultures tables, analytical figures, and reference diagrams. The 3D Cell Cultures report is presented in an efficient way that involves basic dialect, basic 3D Cell Cultures outline, agreements, and certain facts as per solace and comprehension.

Segmentation by Application: Tissue Engineering Tumor Model Stem Cell Research Drug Discovery

Segmentation by Type: Membrane Type Foam / gel Type Microcarriers Type

The Essential Content Covered in the Global3D Cell Cultures Market Report:

* Top Key Company Profiles. * Main Business and Rival Information * SWOT Analysis and PESTEL Analysis * Production, Sales, Revenue, Price and Gross Margin * Market Share and Size

The report provides a 6-year forecast (2020-2026) assessed based on how the 3D Cell Cultures market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Key Questions Answered In this Report:

What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2026?

Which region would have high demand for product in the upcoming years?

What are the factors driving the growth of the market?

Which sub-market will make the most significant contribution to the market?

What are the market opportunities for existing and entry-level players?

What are various long-term and short-term strategies adopted by the market players?

What are the key business strategies being adopted by new entrants in the 3D Cell Cultures Market?

Get Full Customize report or for any Special Discount [emailprotected] https://www.reporthive.com/request_customization/2390765

Table of Contents

Market Overview: This is the first section of the report that includes an overview of the scope of products offered in the global 3D Cell Cultures market, segments by product and application, and market size.

Market Competition by Player: Here, the report shows how the competition in the global 3D Cell Cultures market is growing or decreasing based on deep analysis of market concentrate rate, competitive situations and trends, expansions, merger and acquisition deals, and other subjects. It also shows how different companies are progressing in the global 3D Cell Cultures market in terms of revenue, production, sales, and market share.

Company Profiles and Sales Data: This part of the report is very important as it gives statistical as well as other types of analysis of leading manufacturers in the global 3D Cell Cultures market. It assesses each and every player studied in the report on the basis of main business, gross margin, revenue, sales, price, competitors, manufacturing base, product specification, product application, and product category.

Market Status and Outlook by Region: The report studies the status and outlook of different regional markets such as Europe, North America, the MEA, Asia Pacific, and South America. All of the regional markets researched about in the report are examined based on price, gross margin, revenue, production, and sales. Here, the size and CAGR of the regional markets are also provided.

Market by Product: This section carefully analyzes all product segments of the global 3D Cell Cultures market.

Market by Application: Here, various application segments of the global 3D Cell Cultures market are taken into account for research study.

Market Forecast: It starts with revenue forecast and then continues with sales, sales growth rate, and revenue growth rate forecasts of the global 3D Cell Cultures market. The forecasts are also provided taking into consideration product, application, and regional segments of the global 3D Cell Cultures market.

Upstream Raw Materials: This section includes industrial chain analysis, manufacturing cost structure analysis, and key raw materials analysis of the global 3D Cell Cultures market.

Marketing Strategy Analysis, Distributors: Here, the research study digs deep into behavior and other factors of downstream customers, distributors, development trends of marketing channels, and marketing channels such as indirect marketing and direct marketing.

Research Findings and Conclusion: This section is solely dedicated to the conclusion and findings of the research study on the global 3D Cell Cultures market.

Appendix: This is the last section of the report that focuses on data sources, viz. primary and secondary sources, market breakdown and data triangulation, market size estimation, research programs and design, research approach and methodology, and the publishers disclaimer.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2390765

Why Go For Report Hive Research? Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :

Report Hive Research

Website: https://www.reporthive.com

Email: [emailprotected]

Speak to Research Analyst: +1-312-604-7084

More here:
Trending Now: COVID-19 impact on 3D Cell Cultures Market Variables, Information, Emerging Trends, Analysis and Forecast 2020-2026 | Sigma, Lonza, 3D...

Researchers Discover Stem Cells in Optic Nerve that Preserve Vision – Newswise

By Stem Cell Treatment

Newswise Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding, published this week in the journalProceedings of the National Academy of Sciences(PNAS), presents a new theory on why the most common form of glaucoma may develop and provides potential new ways to treat a leading cause of blindness in American adults.

We believe these cells, called neural progenitor cells, are present in the optic nerve tissue at birth and remain for decades, helping to nourish the nerve fibers that form the optic nerve, said study leaderSteven Bernstein, MD, PhD, Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences at the University of Maryland School of Medicine. Without these cells, the fibers may lose their resistance to stress, and begin to deteriorate, causing damage to the optic nerve, which may ultimately lead to glaucoma.

The study was funded by the National Institutes of Healths National Eye Institute (NEI), and a number of distinguished researchers served as co-authors on the study.

More than 3 million Americans have glaucoma, which results from damage to the optic nerve, causing blindness in 120,000 U.S. patients. This nerve damage is usually related to increased pressure in the eye due to a buildup of fluid that does not drain properly. Blind spots can develop in a patients visual field that gradually widen over time.

This is the first time that neural progenitor cells have been discovered in the optic nerve. Without these cells, the nerve is unable to repair itself from damage caused by glaucoma or other conditions. This may lead to permanent vision loss and disability, said Dr. Bernstein. The presence of neural stem/progenitor cells opens the door to new treatments to repair damage to the optic nerve, which is very exciting news.

To make the research discovery, Dr. Bernstein and his team examined a narrow band of tissue called the optic nerve lamina. Less than 1 millimeter wide, the lamina lies between the light-sensitive retina tissue at the back of the eye and the optic nerve. The long nerve cell fibers extend from the retina through the lamina, into the optic nerve. What the researchers discovered is that the lamina progenitor cells may be responsible for insulating the fibers immediately after they leave the eye, supporting the connections between nerve cells on the pathway to the brain.

The stem cells in the lamina niche bathes these neuron extensions with growth factors, as well as aiding in the formation of the insulating sheath. The researchers were able to confirm the presence of these stem cells by using antibodies and genetically modified animals that identified the specific protein markers on neuronal stem cells.

It took 52 trials to successfully grow the lamina progenitor cells in a culture, said Dr. Bernstein, so this was a challenging process. Dr. Bernstein and his collaborators needed to identify the correct mix of growth factors and other cell culture conditions that would be most conducive for the stem cells to grow and replicate. Eventually the research team found the stem cells could be coaxed into differentiating into several different types of neural cells. These include neurons and glial cells, which are known to be important for cell repair and cell replacement in different brain regions.

This discovery may prove to be game-changing for the treatment of eye diseases that affect the optic nerve. Dr. Bernstein and his research team plan to use genetically modified mice to see how the depletion of lamina progenitor cells contributes to diseases such as glaucoma and prevents repair.

Future research is needed to explore the neural progenitors repair mechanisms. If we can identify the critical growth factors that these cells secrete, they may be potentially useful as a cocktail to slow the progression of glaucoma and other age-related vision disorders.Dr. Bernstein added.

The work was supported by NEI grant RO1EY015304, and by a National Institutes of Health shared instrument grant 1S10RR26870-1.

This exciting discovery could usher in a sea change in the field of age-related diseases that cause vision loss, saidE. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. "New treatment options are desperately needed for the millions of patients whose vision is severely impacted by glaucoma, and I think this research will provide new hope for them.

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States.It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 45 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicineand the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for nearly 2 million patients each year. The School of Medicine has more than $540 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 student trainees, residents, and fellows. The combined School of Medicine and Medical System (University of Maryland Medicine) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8thhighest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visitmedschool.umaryland.edu

Originally posted here:
Researchers Discover Stem Cells in Optic Nerve that Preserve Vision - Newswise

The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19 – DocWire News

By Stem Cell Treatment

This article was originally published here

Curr Stem Cell Res Ther. 2020 Jul 29. doi: 10.2174/1574888X15999200729161539. Online ahead of print.

ABSTRACT

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since Dec 2019, known as COVID-19 or 19-nCoV, has led to a major concern of the potential for not only an epidemic but a pandemic in China and now it seems to be a public health problem all over the world. The general mortality rate of the COVID-19 was about 3%. However, the mortality risk seems to be a significant increase in elderly and cases with chronic disease, who are more likely to develop into acute respiratory distress syndrome (ARDS). There still lacks effective methods for ARDS of COVID-19 patients and the prognosis was poor. Mesenchyma stem cells (MSCs) based treatment has the advantage of targeting numerous pathophysiological components of ARDS by secreting a series of cell factors, exerting anti-inflammatory, antioxidative, immunomodulatory, antiapoptotic, and proangiogenic effects, resulting in significant structural and functional recovery following ARDS in various preclinical models. And recently pilot clinical studies indicated MSCs based therapy was promise in treatment of ARDS caused by SARS-CoV-2. However, little is known about MSCs therapy for ARDS caused by COVID-19.

PMID:32729428 | DOI:10.2174/1574888X15999200729161539

Link:
The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19 - DocWire News

→←